Overview
Pineal parenchymal tumor of intermediate differentiation (PPTID) is a rare brain tumor that arises from the pineal gland, a small endocrine organ located deep in the center of the brain. PPTID is classified by the World Health Organization as a grade II or III tumor, falling on a spectrum between the more benign pineocytoma and the highly aggressive pineoblastoma. These tumors originate from the specialized cells (pinealocytes) of the pineal parenchyma and primarily affect the central nervous system. Because of the pineal gland's location near the cerebral aqueduct, tumor growth frequently leads to obstructive hydrocephalus — a dangerous buildup of cerebrospinal fluid within the brain — which causes symptoms such as headaches, nausea, vomiting, visual disturbances (particularly Parinaud syndrome, characterized by difficulty looking upward), and altered consciousness. Other symptoms may include gait abnormalities, cognitive changes, and fatigue. PPTID can occur in both children and adults, though it is most commonly diagnosed in adults. The clinical behavior of PPTID is variable; some tumors behave in a relatively indolent fashion while others may be more locally aggressive or, rarely, disseminate through the cerebrospinal fluid pathways. Diagnosis typically involves magnetic resonance imaging (MRI) of the brain followed by histopathological examination of tumor tissue obtained through biopsy or surgical resection. Treatment generally involves maximal safe surgical resection when feasible, often followed by adjuvant radiation therapy. The role of chemotherapy remains less well defined and is sometimes considered for higher-grade or recurrent tumors. Management of hydrocephalus, through endoscopic third ventriculostomy or ventriculoperitoneal shunting, is often a critical component of initial treatment. Prognosis is intermediate between pineocytoma and pineoblastoma, with outcomes depending on the degree of differentiation, extent of resection, and individual tumor biology.
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Pineal parenchymal tumor of intermediate differentiation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Pineal parenchymal tumor of intermediate differentiation at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Pineal parenchymal tumor of intermediate differentiation.
Community
No community posts yet. Be the first to share your experience with Pineal parenchymal tumor of intermediate differentiation.
Start the conversation →Latest news about Pineal parenchymal tumor of intermediate differentiation
No recent news articles for Pineal parenchymal tumor of intermediate differentiation.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Pineal parenchymal tumor of intermediate differentiation
What is Pineal parenchymal tumor of intermediate differentiation?
Pineal parenchymal tumor of intermediate differentiation (PPTID) is a rare brain tumor that arises from the pineal gland, a small endocrine organ located deep in the center of the brain. PPTID is classified by the World Health Organization as a grade II or III tumor, falling on a spectrum between the more benign pineocytoma and the highly aggressive pineoblastoma. These tumors originate from the specialized cells (pinealocytes) of the pineal parenchyma and primarily affect the central nervous system. Because of the pineal gland's location near the cerebral aqueduct, tumor growth frequently lea
How is Pineal parenchymal tumor of intermediate differentiation inherited?
Pineal parenchymal tumor of intermediate differentiation follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Pineal parenchymal tumor of intermediate differentiation?
16 specialists and care centers treating Pineal parenchymal tumor of intermediate differentiation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.